# EDGAR Filing Document

**Accession Number:** 0001559109
**File Stem:** 0000940400-26-012462
**Filing Date:** 2026-3
**Character Count:** 53258
**Document Hash:** 2dc522a824fd20a392ba22d9368a4510
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000940400-26-012462.hdr.sgml**: 20260331

**ACCESSION NUMBER**: 0000940400-26-012462

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20260130

**FILED AS OF DATE**: 20260331

**DATE AS OF CHANGE**: 20260331

**PERIOD START**: 20261031

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ETFis Series Trust I
- **CENTRAL INDEX KEY:** 0001559109

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1031

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-22819
- **FILM NUMBER:** 26819832

**BUSINESS ADDRESS:**
- **STREET 1:** 1301 AVENUE OF THE AMERICAS
- **STREET 2:** 14TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **BUSINESS PHONE:** 2125934383

**MAIL ADDRESS:**
- **STREET 1:** 1301 AVENUE OF THE AMERICAS
- **STREET 2:** 14TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ETF Actively Managed Trust
- **DATE OF NAME CHANGE:** 20120926

## Series and Classes Contracts Data

### Virtus Biotech Clinical Trials ETF (Series ID: S000047353)

| Class ID   | Class Name                         | Ticker Symbol   |
|:---|:---|:---|
| C000148681 | Virtus Biotech Clinical Trials ETF | BBC             |

## Nport-Ex

Schedule of Investments – Virtus Biotech Clinical Trials ETF (Formerly, Virtus LifeSci Biotech Clinical Trials ETF)

January 31, 2026 (unaudited)

---

| | | |
|:---|:---|:---|
| **Security Description**  | **Shares**  | **Value**  |
| **COMMON STOCKS - 99.8%** |  |  |
| **Health Care - 99.8%** |  |  |
| 4D Molecular Therapeutics, Inc.\* | 25989 | $230263 |
| AbCellera Biologics, Inc. (Canada)\*<sup>(1)</sup> | 77824 | 281723 |
| Allogene Therapeutics, Inc.\* | 186572 | 343293 |
| Altimmune, Inc.\* | 53460 | 299376 |
| Alumis, Inc.\* | 24519 | 600961 |
| Amylyx Pharmaceuticals, Inc.\* | 21505 | 307307 |
| AnaptysBio, Inc.\* | 6268 | 297166 |
| Annexon, Inc.\* | 56685 | 353714 |
| Apogee Therapeutics, Inc.\* | 3655 | 239439 |
| Arbutus Biopharma Corp.\* | 59815 | 247036 |
| Arcellx, Inc.\*<sup>(1)</sup> | 3919 | 267707 |
| Arcus Biosciences, Inc.\* | 13085 | 275308 |
| ArriVent Biopharma, Inc.\*<sup>(1)</sup> | 11537 | 259467 |
| Arvinas, Inc.\* | 22396 | 299659 |
| Assembly Biosciences, Inc.\* | 7804 | 201148 |
| AtaiBeckley, Inc. (Germany)\*<sup>(1)</sup> | 65670 | 246919 |
| Beam Therapeutics, Inc.\* | 10298 | 284431 |
| Belite Bio, Inc.\*<sup>(1)(2)</sup> | 1993 | 336817 |
| Bicara Therapeutics, Inc.\* | 15244 | 256099 |
| Bicycle Therapeutics PLC (United Kingdom)\*<sup>(2)</sup> | 37816 | 242779 |
| Biohaven Ltd.\* | 24433 | 289042 |
| Capricor Therapeutics, Inc.\*<sup>(1)</sup> | 10827 | 237003 |
| Celcuity, Inc.\*<sup>(1)</sup> | 2677 | 292917 |
| Celldex Therapeutics, Inc.\* | 10242 | 251953 |
| Centessa Pharmaceuticals PLC\*<sup>(2)</sup> | 10626 | 261081 |
| CG oncology, Inc.\*<sup>(1)</sup> | 6880 | 358104 |
| Cogent Biosciences, Inc.\* | 6690 | 240238 |
| Compass Pathways PLC (United Kingdom)\*<sup>(2)</sup> | 41800 | 279642 |
| Compass Therapeutics, Inc.\* | 54598 | 349427 |
| Corvus Pharmaceuticals, Inc.\* | 33658 | 696721 |
| Cullinan Therapeutics, Inc.\* | 23635 | 282675 |
| Cytokinetics, Inc.\* | 4498 | 284229 |
| CytomX Therapeutics, Inc.\* | 67237 | 382579 |
| Definium Therapeutics, Inc.\* | 22449 | 378939 |
| Denali Therapeutics, Inc.\*<sup>(1)</sup> | 15668 | 340622 |
| Dianthus Therapeutics, Inc.\* | 6688 | 357072 |
| Disc Medicine, Inc.\* | 3068 | 237218 |
| Dyne Therapeutics, Inc.\* | 14621 | 261570 |
| Edgewise Therapeutics, Inc.\* | 11928 | 335773 |
| Engene Holdings, Inc. (Canada)\* | 33300 | 317349 |
| Enliven Therapeutics, Inc.\*<sup>(1)</sup> | 16709 | 441953 |
| Erasca, Inc.\* | 78256 | 822471 |
| EyePoint, Inc.\* | 17620 | 238222 |
| Fulcrum Therapeutics, Inc.\* | 21670 | 232519 |
| GH Research PLC (Ireland)\*<sup>(1)</sup> | 21612 | 338444 |
| Gossamer Bio, Inc.\* | 78256 | 178424 |
| Ideaya Biosciences, Inc.\* | 8280 | 266533 |
| Immatics NV (Germany)\* | 28060 | 267973 |
| Immunome, Inc.\* | 14395 | 354405 |
| Immunovant, Inc.\* | 10663 | 277238 |
| Inhibrx Biosciences, Inc.\* | 3540 | 269996 |
| Intellia Therapeutics, Inc.\*<sup>(1)</sup> | 31233 | 410714 |
| Invivyd, Inc.\* | 121433 | 211293 |
| Ironwood Pharmaceuticals, Inc.\* | 78695 | 384819 |
| Jade Biosciences, Inc.<sup>(1)</sup> | 18807 | 293577 |
| Janux Therapeutics, Inc.\* | 18414 | 252456 |
| Keros Therapeutics, Inc.\* | 13097 | 234567 |

---

---

| | | |
|:---|:---|:---|
| **Security Description**  | **Shares**  | **Value**  |
| **COMMON STOCKS (continued)** |  |  |
| **Health Care (continued)** |  |  |
| Kodiak Sciences, Inc.\* | 11832 | $269415 |
| Kymera Therapeutics, Inc.\*<sup>(1)</sup> | 3141 | 228319 |
| Lexeo Therapeutics, Inc.\* | 28837 | 213682 |
| Liquidia Corp.\*<sup>(1)</sup> | 8439 | 357729 |
| Maze Therapeutics, Inc.\*<sup>(1)</sup> | 7250 | 315955 |
| MBX Biosciences, Inc.\*<sup>(1)</sup> | 9436 | 347717 |
| MeiraGTx Holdings PLC\* | 31584 | 240354 |
| Mereo Biopharma Group PLC (United Kingdom)\*<sup>(2)</sup> | 129828 | 57124 |
| Mineralys Therapeutics, Inc.\* | 7634 | 235814 |
| Monopar Therapeutics, Inc.\* | 3775 | 227935 |
| Monte Rosa Therapeutics, Inc.\* | 17272 | 354421 |
| MoonLake Immunotherapeutics\* | 19048 | 298482 |
| Nektar Therapeutics\* | 5150 | 192250 |
| Neurogene, Inc.\*<sup>(1)</sup> | 13466 | 237810 |
| Newamsterdam Pharma Co. NV (Netherlands)\* | 7563 | 235361 |
| Nurix Therapeutics, Inc.\* | 14772 | 244033 |
| Nuvalent, Inc. Class A\*<sup>(1)</sup> | 2688 | 276568 |
| Olema Pharmaceuticals, Inc.\* | 8524 | 219237 |
| Omeros Corp.\*<sup>(1)</sup> | 27759 | 324503 |
| ORIC Pharmaceuticals, Inc.\* | 30034 | 308149 |
| Oruka Therapeutics, Inc.\*<sup>(1)</sup> | 9334 | 319503 |
| Palvella Therapeutics, Inc.\* | 2857 | 219103 |
| Pharvaris NV (Netherlands)\* | 11661 | 315430 |
| Praxis Precision Medicines, Inc.\* | 1047 | 328758 |
| Precigen, Inc.\* | 76349 | 342807 |
| Prime Medicine, Inc.\*<sup>(1)</sup> | 68714 | 261800 |
| ProKidney Corp.\*<sup>(1)</sup> | 127478 | 252406 |
| Protagonist Therapeutics, Inc.\* | 2955 | 241719 |
| Prothena Corp. PLC (Ireland)\* | 27194 | 239579 |
| Rapport Therapeutics, Inc.\* | 9308 | 247686 |
| RAPT Therapeutics, Inc.\* | 7656 | 441598 |
| Recursion Pharmaceuticals, Inc. Class A\*<sup>(1)</sup> | 65064 | 272618 |
| REGENXBIO, Inc.\* | 20313 | 226693 |
| Relay Therapeutics, Inc.\* | 35085 | 268751 |
| Replimune Group, Inc.\* | 27675 | 194555 |
| Revolution Medicines, Inc.\* | 3570 | 346112 |
| Rezolute, Inc.\* | 156515 | 522760 |
| Rigel Pharmaceuticals, Inc.\* | 6909 | 240848 |
| Rocket Pharmaceuticals, Inc.\* | 83104 | 289202 |
| Sana Biotechnology, Inc.\* | 54810 | 242808 |
| Savara, Inc.\* | 40711 | 219839 |
| Scholar Rock Holding Corp.\* | 6011 | 266528 |
| Septerna, Inc.\* | 11074 | 258467 |
| Sionna Therapeutics, Inc.\* | 6587 | 278367 |
| Soleno Therapeutics, Inc.\* | 5418 | 208918 |
| Spyre Therapeutics, Inc.\* | 8380 | 267992 |
| Stoke Therapeutics, Inc.\*<sup>(1)</sup> | 8699 | 263928 |
| Structure Therapeutics, Inc.\*<sup>(2)</sup> | 4201 | 371578 |
| Summit Therapeutics, Inc.\*<sup>(1)</sup> | 16034 | 232172 |
| Tango Therapeutics, Inc.\* | 30131 | 349821 |
| Taysha Gene Therapies, Inc.\* | 48657 | 219443 |
| Tectonic Therapeutic, Inc.\*<sup>(1)</sup> | 14256 | 284977 |
| Terns Pharmaceuticals, Inc.\* | 6261 | 216631 |
| Tyra Biosciences, Inc.\* | 12450 | 383709 |
| uniQure NV (Netherlands)\* | 14441 | 328100 |
| Upstream Bio, Inc.\*<sup>(1)</sup> | 10379 | 322579 |

---

Schedule of Investments - Virtus Biotech Clinical Trials ETF (Formerly, Virtus LifeSci Biotech Clinical Trials ETF) (continued)

January 31, 2026 (unaudited)

---

| | | |
|:---|:---|:---|
| **Security Description**  | **Shares**  | **Value**  |
| **COMMON STOCKS (continued)** |  |  |
| **Health Care (continued)** |  |  |
| Vaxcyte, Inc.\* | 6332 | $339205 |
| Ventyx Biosciences, Inc.\* | 34399 | 479866 |
| Vera Therapeutics, Inc.\* | 5657 | 244722 |
| Verastem, Inc.\* | 29315 | 178822 |
| Viking Therapeutics, Inc.\* | 7597 | 220617 |
| Vir Biotechnology, Inc.\* | 42110 | 313298 |
| Viridian Therapeutics, Inc.\* | 8719 | 287727 |
| WaVe Life Sciences Ltd.\* | 17012 | 220135 |
| Xencor, Inc.\* | 17053 | 206171 |
| Xenon Pharmaceuticals, Inc. (Canada)\* | 6393 | 262177 |
| Xeris Biopharma Holdings, Inc.\* | 39291 | 289182 |
| Zenas Biopharma, Inc.\*<sup>(1)</sup> | 6941 | 127506 |
| Zymeworks, Inc.\* | 11057 | 249114 |
| Total Health Care |  | 36671555 |
| **Total Common Stocks** |  |  |
| (Cost $30,819,416) |  | **36671555** |
| **SECURITIES LENDING COLLATERAL - 3.2%** |  |  |
| **Money Market Fund - 3.2%** |  |  |
| Dreyfus Government Cash Management Fund, Institutional Shares, 3.58%<sup>(3)(4)</sup> |  |  |
| (Cost $1,165,588) | 1165588 | **1165588** |
| **TOTAL INVESTMENTS - 103.0%** |  |  |
| (Cost $31,985,004) |  | **37837143** |
| Liabilities in Excess of Other Assets - (3.0)% |  | (1085125) |
| **Net Assets - 100.0%** |  | $**36752018** |

---

\* Non-income producing security.

(1) All or a portion of the security was on loan. The aggregate market value of securities on loan was $5,016,151; total market value of collateral held by the Fund was $5,355,320. Market value of the collateral held includes non-cash U.S. Treasury securities having a value of $4,189,732.

(2) American Depositary Receipts.

(3) Represents securities purchased with cash collateral received for securities on loan.

(4) The rate shown reflects the seven-day yield as of January 31, 2026.

Schedule of Investments - Virtus Biotech Clinical Trials ETF (Formerly, Virtus LifeSci Biotech Clinical Trials ETF) (continued)

January 31, 2026 (unaudited)

**Fair Value Measurements**

The Fund utilizes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. Level 1 includes unadjusted quoted prices in active markets for identical assets or liabilities that the Fund has the ability to access. Level 2 includes observable inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. These inputs may include quoted prices for the identical instrument on an inactive market, prices for similar securities, interest rates, prepayment speeds, credit risk, yield curves, default rates and similar data. Level 3 includes unobservable inputs for the asset or liability, to the extent relevant observable inputs are not available; representing the Fund's own assumptions about the assumptions a market participant would use in valuing the asset or liability, and would be based on the best information available. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.

The following table summarizes valuation of the Fund's investments under the fair value hierarchy levels as of January 31, 2026.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Level 1** | **Level 2** | **Level 3** | **Total** |
| **Asset Valuation Inputs** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common Stocks | $36671555 | $— | $— | $36671555 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Money Market Fund | 1165588 |  |  | 1165588 |
| **Total** | $**37837143** | $**—** | $**—** | $**37837143** |

---

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** ETFis Series Trust I

- **b. Investment Company Act file number:** 811-22819

- **c. CIK number of Registrant:** 0001559109

- **d. LEI of Registrant:** 5493002CWTVLBPSYFT98

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 1301 Avenue of the Americas

  - **City:** New York

  - **State:** NY

  - **Foreign country:** US

  - **Zip / Postal Code:** 10019

  - **Telephone number:** 1-888-383-0553

**Item A.2. Information about the Series.**

- **a. Name of Series:** Virtus LifeSci Biotech Clinical Trials ETF

- **b. EDGAR series identifier (if any):** S000047353

- **c. LEI of Series:** 549300YTBZ16PIXEKJ82

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2026-10-31

- **b. Date as of which information is reported:** 2026-01-30

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $37941378.81

**Total Liabilities:** $1189395.54

**Net Assets:** $36751983.27

**Cash Not Reported:** $97615.76

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000148681 | 16.82%               | 4.23%                | 5.57%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $1202.80                 | $3620734.17                                |
| Month 2  | $5062776.26              | $-3988320.46                               |
| Month 3  | $0.00                    | $2003321.73                                |

### Schedule of Portfolio Investments

| Name                           | Title                          | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| ProKidney Corp                 | ProKidney Corp                 | CUSIP: 74291D104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    127478 | NS      | $252406.44    | 0.69%             |  |  |  | No            |                  1 | On Loan: —       |
| Intellia Therapeutics Inc      | Intellia Therapeutics Inc      | CUSIP: 45826J105<br>LEI: 5493002T5BCPE5DZC723 | Long             | EC               | CORP              | US        |     31233 | NS      | $410713.95    | 1.12%             |  |  |  | No            |                  1 | On Loan: —       |
| Dyne Therapeutics Inc          | Dyne Therapeutics Inc          | CUSIP: 26818M108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     14621 | NS      | $261569.69    | 0.71%             |  |  |  | No            |                  1 | On Loan: No      |
| Immunovant Inc                 | Immunovant Inc                 | CUSIP: 45258J102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     10663 | NS      | $277238.00    | 0.75%             |  |  |  | No            |                  1 | On Loan: No      |
| Kymera Therapeutics Inc        | Kymera Therapeutics Inc        | CUSIP: 501575104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      3141 | NS      | $228319.29    | 0.62%             |  |  |  | No            |                  1 | On Loan: —       |
| Prime Medicine Inc             | Prime Medicine Inc             | CUSIP: 74168J101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     68714 | NS      | $261800.34    | 0.71%             |  |  |  | No            |                  1 | On Loan: —       |
| Newamsterdam Pharma Co NV      | Newamsterdam Pharma Co NV      | CUSIP: 000000000<br>LEI: 984500B6549TF6E14D36 | Long             | EC               | CORP              | NL        |      7563 | NS      | $235360.56    | 0.64%             |  |  |  | No            |                  1 | On Loan: No      |
| Bicara Therapeutics Inc        | Bicara Therapeutics Inc        | CUSIP: 055477103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     15244 | NS      | $256099.20    | 0.70%             |  |  |  | No            |                  1 | On Loan: No      |
| MBX Biosciences Inc            | MBX Biosciences Inc            | CUSIP: 55287L101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      9436 | NS      | $347716.60    | 0.95%             |  |  |  | No            |                  1 | On Loan: —       |
| Invivyd Inc                    | Invivyd Inc                    | CUSIP: 00534A102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    121433 | NS      | $211293.42    | 0.57%             |  |  |  | No            |                  1 | On Loan: No      |
| Allogene Therapeutics Inc      | Allogene Therapeutics Inc      | CUSIP: 019770106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    186572 | NS      | $343292.48    | 0.93%             |  |  |  | No            |                  1 | On Loan: No      |
| Replimune Group Inc            | Replimune Group Inc            | CUSIP: 76029N106<br>LEI: 549300AY704NEIRC4K64 | Long             | EC               | CORP              | US        |     27675 | NS      | $194555.25    | 0.53%             |  |  |  | No            |                  1 | On Loan: No      |
| Omeros Corp                    | Omeros Corp                    | CUSIP: 682143102<br>LEI: 549300CJWLXX2MXVVV71 | Long             | EC               | CORP              | US        |     27759 | NS      | $324502.71    | 0.88%             |  |  |  | No            |                  1 | On Loan: —       |
| DREYFUS GOVERNMENT CASH MANAGE | DREYFUS GOVERNMENT CASH MANAGE | CUSIP: 000000000<br>LEI: N/A                  | Long             | STIV             | RF                | US        |   1165588 | NS      | $1165588.36   | 3.17%             |  |  |  | No            |                  1 | On Loan: No      |
| Gossamer Bio Inc               | Gossamer Bio Inc               | CUSIP: 38341P102<br>LEI: 549300ZOC0N2W6PSFR58 | Long             | EC               | CORP              | US        |     78256 | NS      | $178423.68    | 0.49%             |  |  |  | No            |                  1 | On Loan: No      |
| Kodiak Sciences Inc            | Kodiak Sciences Inc            | CUSIP: 50015M109<br>LEI: 254900IXI5NI8C9OQE24 | Long             | EC               | CORP              | US        |     11832 | NS      | $269414.64    | 0.73%             |  |  |  | No            |                  1 | On Loan: No      |
| EyePoint Inc                   | EyePoint Inc                   | CUSIP: 30233G209<br>LEI: 549300QE1RU34T50MR69 | Long             | EC               | CORP              | US        |     17620 | NS      | $238222.40    | 0.65%             |  |  |  | No            |                  1 | On Loan: No      |
| Upstream Bio Inc               | Upstream Bio Inc               | CUSIP: 91678A107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     10379 | NS      | $322579.32    | 0.88%             |  |  |  | No            |                  1 | On Loan: —       |
| AbCellera Biologics Inc        | AbCellera Biologics Inc        | CUSIP: 00288U106<br>LEI: 9845000861BC95FF9F73 | Long             | EC               | CORP              | CA        |     77824 | NS      | $281722.88    | 0.77%             |  |  |  | No            |                  1 | On Loan: —       |
| Tectonic Therapeutic Inc       | Tectonic Therapeutic Inc       | CUSIP: 878972108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     14256 | NS      | $284977.44    | 0.78%             |  |  |  | No            |                  1 | On Loan: —       |
| Cytokinetics Inc               | Cytokinetics Inc               | CUSIP: 23282W605<br>LEI: 549300BE5DY1HW7IHA64 | Long             | EC               | CORP              | US        |      4498 | NS      | $284228.62    | 0.77%             |  |  |  | No            |                  1 | On Loan: No      |
| ORIC Pharmaceuticals Inc       | ORIC Pharmaceuticals Inc       | CUSIP: 68622P109<br>LEI: 54930033FJRNEYBW0L25 | Long             | EC               | CORP              | US        |     30034 | NS      | $308148.84    | 0.84%             |  |  |  | No            |                  1 | On Loan: No      |
| Bicycle Therapeutics PLC       | Bicycle Therapeutics PLC       | CUSIP: 088786108<br>LEI: 213800XKUI6R7GKC3E43 | Long             | EC               | CORP              | GB        |     37816 | NS      | $242778.72    | 0.66%             |  |  |  | No            |                  1 | On Loan: No      |
| Rigel Pharmaceuticals Inc      | Rigel Pharmaceuticals Inc      | CUSIP: 766559702<br>LEI: 529900KPTNUS5J8K9K66 | Long             | EC               | CORP              | US        |      6909 | NS      | $240847.74    | 0.66%             |  |  |  | No            |                  1 | On Loan: No      |
| Sana Biotechnology Inc         | Sana Biotechnology Inc         | CUSIP: 799566104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     54810 | NS      | $242808.30    | 0.66%             |  |  |  | No            |                  1 | On Loan: No      |
| Stoke Therapeutics Inc         | Stoke Therapeutics Inc         | CUSIP: 86150R107<br>LEI: 549300RD25SS2DIJHJ67 | Long             | EC               | CORP              | US        |      8699 | NS      | $263927.66    | 0.72%             |  |  |  | No            |                  1 | On Loan: —       |
| Verastem Inc                   | Verastem Inc                   | CUSIP: 92337C203<br>LEI: 549300IY0EFBIU8NQC81 | Long             | EC               | CORP              | US        |     29315 | NS      | $178821.50    | 0.49%             |  |  |  | No            |                  1 | On Loan: No      |
| Annexon Inc                    | Annexon Inc                    | CUSIP: 03589W102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     56685 | NS      | $353714.40    | 0.96%             |  |  |  | No            |                  1 | On Loan: No      |
| Zenas Biopharma Inc            | Zenas Biopharma Inc            | CUSIP: 98937L105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      6941 | NS      | $127506.17    | 0.35%             |  |  |  | No            |                  1 | On Loan: —       |
| Oruka Therapeutics Inc         | Oruka Therapeutics Inc         | CUSIP: 687604108<br>LEI: 529900TG7O4ESUDMGI54 | Long             | EC               | CORP              | US        |      9334 | NS      | $319502.82    | 0.87%             |  |  |  | No            |                  1 | On Loan: —       |
| Immatics NV                    | Immatics NV                    | CUSIP: 000000000<br>LEI: 984500DC691EZ96AF394 | Long             | EC               | CORP              | DE        |     28060 | NS      | $267973.00    | 0.73%             |  |  |  | No            |                  1 | On Loan: No      |
| Savara Inc                     | Savara Inc                     | CUSIP: 805111101<br>LEI: 5493002JO0WM3YMJXG33 | Long             | EC               | CORP              | US        |     40711 | NS      | $219839.40    | 0.60%             |  |  |  | No            |                  1 | On Loan: No      |
| Compass Therapeutics Inc       | Compass Therapeutics Inc       | CUSIP: 20454B104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     54598 | NS      | $349427.20    | 0.95%             |  |  |  | No            |                  1 | On Loan: No      |
| Vaxcyte Inc                    | Vaxcyte Inc                    | CUSIP: 92243G108<br>LEI: 254900M7NMHTGASX8D95 | Long             | EC               | CORP              | US        |      6332 | NS      | $339205.24    | 0.92%             |  |  |  | No            |                  1 | On Loan: No      |
| Arcus Biosciences Inc          | Arcus Biosciences Inc          | CUSIP: 03969F109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     13085 | NS      | $275308.40    | 0.75%             |  |  |  | No            |                  1 | On Loan: No      |
| Structure Therapeutics Inc     | Structure Therapeutics Inc     | CUSIP: 86366E106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      4201 | NS      | $371578.45    | 1.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Arcellx Inc                    | Arcellx Inc                    | CUSIP: 03940C100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      3919 | NS      | $267706.89    | 0.73%             |  |  |  | No            |                  1 | On Loan: —       |
| Edgewise Therapeutics Inc      | Edgewise Therapeutics Inc      | CUSIP: 28036F105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     11928 | NS      | $335773.20    | 0.91%             |  |  |  | No            |                  1 | On Loan: No      |
| Apogee Therapeutics Inc        | Apogee Therapeutics Inc        | CUSIP: 03770N101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      3655 | NS      | $239439.05    | 0.65%             |  |  |  | No            |                  1 | On Loan: No      |
| Monte Rosa Therapeutics Inc    | Monte Rosa Therapeutics Inc    | CUSIP: 61225M102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     17272 | NS      | $354421.44    | 0.96%             |  |  |  | No            |                  1 | On Loan: No      |
| Biohaven Ltd                   | Biohaven Ltd                   | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     24433 | NS      | $289042.39    | 0.79%             |  |  |  | No            |                  1 | On Loan: No      |
| Praxis Precision Medicines Inc | Praxis Precision Medicines Inc | CUSIP: 74006W207<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      1047 | NS      | $328758.00    | 0.89%             |  |  |  | No            |                  1 | On Loan: No      |
| Nuvalent Inc                   | Nuvalent Inc                   | CUSIP: 670703107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      2688 | NS      | $276568.32    | 0.75%             |  |  |  | No            |                  1 | On Loan: —       |
| Revolution Medicines Inc       | Revolution Medicines Inc       | CUSIP: 76155X100<br>LEI: 549300JU3X0LBCQ65892 | Long             | EC               | CORP              | US        |      3570 | NS      | $346111.50    | 0.94%             |  |  |  | No            |                  1 | On Loan: No      |
| Keros Therapeutics Inc         | Keros Therapeutics Inc         | CUSIP: 492327101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     13097 | NS      | $234567.27    | 0.64%             |  |  |  | No            |                  1 | On Loan: No      |
| Alumis Inc                     | Alumis Inc                     | CUSIP: 022307102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     24519 | NS      | $600960.69    | 1.64%             |  |  |  | No            |                  1 | On Loan: No      |
| Soleno Therapeutics Inc        | Soleno Therapeutics Inc        | CUSIP: 834203309<br>LEI: 5493003LCY77N7FXK844 | Long             | EC               | CORP              | US        |      5418 | NS      | $208918.08    | 0.57%             |  |  |  | No            |                  1 | On Loan: No      |
| ArriVent Biopharma Inc         | ArriVent Biopharma Inc         | CUSIP: 04272N102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     11537 | NS      | $259467.13    | 0.71%             |  |  |  | No            |                  1 | On Loan: —       |
| Jade Biosciences Inc           | Jade Biosciences Inc           | CUSIP: 008064206<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     18807 | NS      | $293577.27    | 0.80%             |  |  |  | No            |                  1 | On Loan: —       |
| Disc Medicine Inc              | Disc Medicine Inc              | CUSIP: 254604101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      3068 | NS      | $237217.76    | 0.65%             |  |  |  | No            |                  1 | On Loan: No      |
| Celcuity Inc                   | Celcuity Inc                   | CUSIP: 15102K100<br>LEI: 25490070W7UU7W2SEY87 | Long             | EC               | CORP              | US        |      2677 | NS      | $292917.34    | 0.80%             |  |  |  | No            |                  1 | On Loan: —       |
| Immunome Inc                   | Immunome Inc                   | CUSIP: 45257U108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     14395 | NS      | $354404.90    | 0.96%             |  |  |  | No            |                  1 | On Loan: No      |
| Beam Therapeutics Inc          | Beam Therapeutics Inc          | CUSIP: 07373V105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     10298 | NS      | $284430.76    | 0.77%             |  |  |  | No            |                  1 | On Loan: No      |
| Enliven Therapeutics Inc       | Enliven Therapeutics Inc       | CUSIP: 29337E102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     16709 | NS      | $441953.05    | 1.20%             |  |  |  | No            |                  1 | On Loan: —       |
| Arbutus Biopharma Corp         | Arbutus Biopharma Corp         | CUSIP: 03879J100<br>LEI: 25490064CESONAUIAS23 | Long             | EC               | CORP              | US        |     59815 | NS      | $247035.95    | 0.67%             |  |  |  | No            |                  1 | On Loan: No      |
| Engene Holdings Inc            | Engene Holdings Inc            | CUSIP: 29286M105<br>LEI: N/A                  | Long             | EC               | CORP              | CA        |     33300 | NS      | $317349.00    | 0.86%             |  |  |  | No            |                  1 | On Loan: No      |
| Vera Therapeutics Inc          | Vera Therapeutics Inc          | CUSIP: 92337R101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      5657 | NS      | $244721.82    | 0.67%             |  |  |  | No            |                  1 | On Loan: No      |
| Tango Therapeutics Inc         | Tango Therapeutics Inc         | CUSIP: 87583X109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     30131 | NS      | $349820.91    | 0.95%             |  |  |  | No            |                  1 | On Loan: No      |
| Monopar Therapeutics Inc       | Monopar Therapeutics Inc       | CUSIP: 61023L207<br>LEI: 549300QJFAI7L6YHKG83 | Long             | EC               | CORP              | US        |      3775 | NS      | $227934.50    | 0.62%             |  |  |  | No            |                  1 | On Loan: No      |
| Prothena Corp PLC              | Prothena Corp PLC              | CUSIP: 000000000<br>LEI: 5299009ZXQ8NIIJ8OL30 | Long             | EC               | CORP              | IE        |     27194 | NS      | $239579.14    | 0.65%             |  |  |  | No            |                  1 | On Loan: No      |
| Recursion Pharmaceuticals Inc  | Recursion Pharmaceuticals Inc  | CUSIP: 75629V104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     65064 | NS      | $272618.16    | 0.74%             |  |  |  | No            |                  1 | On Loan: —       |
| Liquidia Corp                  | Liquidia Corp                  | CUSIP: 53635D202<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      8439 | NS      | $357729.21    | 0.97%             |  |  |  | No            |                  1 | On Loan: —       |
| Rapport Therapeutics Inc       | Rapport Therapeutics Inc       | CUSIP: 75383L102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      9308 | NS      | $247685.88    | 0.67%             |  |  |  | No            |                  1 | On Loan: No      |
| Tyra Biosciences Inc           | Tyra Biosciences Inc           | CUSIP: 90240B106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     12450 | NS      | $383709.00    | 1.04%             |  |  |  | No            |                  1 | On Loan: No      |
| uniQure NV                     | uniQure NV                     | CUSIP: 000000000<br>LEI: 724500RPCTZLFYJZ3S98 | Long             | EC               | CORP              | NL        |     14441 | NS      | $328099.52    | 0.89%             |  |  |  | No            |                  1 | On Loan: No      |
| Protagonist Therapeutics Inc   | Protagonist Therapeutics Inc   | CUSIP: 74366E102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      2955 | NS      | $241719.00    | 0.66%             |  |  |  | No            |                  1 | On Loan: No      |
| Cullinan Therapeutics Inc      | Cullinan Therapeutics Inc      | CUSIP: 230031106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     23635 | NS      | $282674.60    | 0.77%             |  |  |  | No            |                  1 | On Loan: No      |
| WaVe Life Sciences Ltd         | WaVe Life Sciences Ltd         | CUSIP: 000000000<br>LEI: 54930070006GPKFYZ813 | Long             | EC               | CORP              | SG        |     17012 | NS      | $220135.28    | 0.60%             |  |  |  | No            |                  1 | On Loan: No      |
| Sionna Therapeutics Inc        | Sionna Therapeutics Inc        | CUSIP: 829401108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      6587 | NS      | $278366.62    | 0.76%             |  |  |  | No            |                  1 | On Loan: No      |
| Janux Therapeutics Inc         | Janux Therapeutics Inc         | CUSIP: 47103J105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     18414 | NS      | $252455.94    | 0.69%             |  |  |  | No            |                  1 | On Loan: No      |
| Pharvaris NV                   | Pharvaris NV                   | CUSIP: 000000000<br>LEI: 9845003BE146D3B75D32 | Long             | EC               | CORP              | NL        |     11661 | NS      | $315430.05    | 0.86%             |  |  |  | No            |                  1 | On Loan: No      |
| Corvus Pharmaceuticals Inc     | Corvus Pharmaceuticals Inc     | CUSIP: 221015100<br>LEI: 549300I3AVJ8F75NCX65 | Long             | EC               | CORP              | US        |     33658 | NS      | $696720.60    | 1.90%             |  |  |  | No            |                  1 | On Loan: No      |
| RAPT Therapeutics Inc          | RAPT Therapeutics Inc          | CUSIP: 75382E208<br>LEI: 549300MB473BIU78ES48 | Long             | EC               | CORP              | US        |      7656 | NS      | $441598.08    | 1.20%             |  |  |  | No            |                  1 | On Loan: No      |
| Xencor Inc                     | Xencor Inc                     | CUSIP: 98401F105<br>LEI: 549300V5IF65437JKG30 | Long             | EC               | CORP              | US        |     17053 | NS      | $206170.77    | 0.56%             |  |  |  | No            |                  1 | On Loan: No      |
| Rocket Pharmaceuticals Inc     | Rocket Pharmaceuticals Inc     | CUSIP: 77313F106<br>LEI: 549300R7VV82YUIN4Y93 | Long             | EC               | CORP              | US        |     83104 | NS      | $289201.92    | 0.79%             |  |  |  | No            |                  1 | On Loan: No      |
| MeiraGTx Holdings plc          | MeiraGTx Holdings plc          | CUSIP: 000000000<br>LEI: 54930007YV6NYIOGFZ57 | Long             | EC               | CORP              | US        |     31584 | NS      | $240354.24    | 0.65%             |  |  |  | No            |                  1 | On Loan: No      |
| AtaiBeckley Inc                | AtaiBeckley Inc                | CUSIP: 04650F101<br>LEI: 529900HOVZ0MXOBQ5Y47 | Long             | EC               | CORP              | US        |     65670 | NS      | $246919.20    | 0.67%             |  |  |  | No            |                  1 | On Loan: —       |
| Fulcrum Therapeutics Inc       | Fulcrum Therapeutics Inc       | CUSIP: 359616109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     21670 | NS      | $232519.10    | 0.63%             |  |  |  | No            |                  1 | On Loan: No      |
| Denali Therapeutics Inc        | Denali Therapeutics Inc        | CUSIP: 24823R105<br>LEI: 549300ZTQ2HO18L3Q830 | Long             | EC               | CORP              | US        |     15668 | NS      | $340622.32    | 0.93%             |  |  |  | No            |                  1 | On Loan: —       |
| Assembly Biosciences Inc       | Assembly Biosciences Inc       | CUSIP: 045396207<br>LEI: 5299007Y1X8RBDFT8C40 | Long             | EC               | CORP              | US        |      7804 | NS      | $201148.10    | 0.55%             |  |  |  | No            |                  1 | On Loan: No      |
| Arvinas Inc                    | Arvinas Inc                    | CUSIP: 04335A105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     22396 | NS      | $299658.48    | 0.82%             |  |  |  | No            |                  1 | On Loan: No      |
| Erasca Inc                     | Erasca Inc                     | CUSIP: 29479A108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     78256 | NS      | $822470.56    | 2.24%             |  |  |  | No            |                  1 | On Loan: No      |
| Belite Bio Inc                 | Belite Bio Inc                 | CUSIP: 07782B104<br>LEI: 984500BD54036BOEAE79 | Long             | EC               | CORP              | US        |      1993 | NS      | $336817.00    | 0.92%             |  |  |  | No            |                  1 | On Loan: —       |
| Maze Therapeutics Inc          | Maze Therapeutics Inc          | CUSIP: 578784100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      7250 | NS      | $315955.00    | 0.86%             |  |  |  | No            |                  1 | On Loan: —       |
| Altimmune Inc                  | Altimmune Inc                  | CUSIP: 02155H200<br>LEI: 549300EOYCQ8SW3NVE64 | Long             | EC               | CORP              | US        |     53460 | NS      | $299376.00    | 0.81%             |  |  |  | No            |                  1 | On Loan: No      |
| 4D Molecular Therapeutics Inc  | 4D Molecular Therapeutics Inc  | CUSIP: 35104E100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     25989 | NS      | $230262.54    | 0.63%             |  |  |  | No            |                  1 | On Loan: No      |
| Summit Therapeutics Inc        | Summit Therapeutics Inc        | CUSIP: 86627T108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     16034 | NS      | $232172.32    | 0.63%             |  |  |  | No            |                  1 | On Loan: —       |
| MoonLake Immunotherapeutics    | MoonLake Immunotherapeutics    | CUSIP: 61559X104<br>LEI: N/A                  | Long             | EC               | CORP              | CH        |     19048 | NS      | $298482.16    | 0.81%             |  |  |  | No            |                  1 | On Loan: No      |
| CG oncology Inc                | CG oncology Inc                | CUSIP: 156944100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      6880 | NS      | $358104.00    | 0.97%             |  |  |  | No            |                  1 | On Loan: —       |
| Inhibrx Biosciences Inc        | Inhibrx Biosciences Inc        | CUSIP: 45720N103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      3540 | NS      | $269995.80    | 0.73%             |  |  |  | No            |                  1 | On Loan: No      |
| Ironwood Pharmaceuticals Inc   | Ironwood Pharmaceuticals Inc   | CUSIP: 46333X108<br>LEI: 549300PC8MR6QHH6P296 | Long             | EC               | CORP              | US        |     78695 | NS      | $384818.55    | 1.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Xeris Biopharma Holdings Inc   | Xeris Biopharma Holdings Inc   | CUSIP: 98422E103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     39291 | NS      | $289181.76    | 0.79%             |  |  |  | No            |                  1 | On Loan: No      |
| Ideaya Biosciences Inc         | Ideaya Biosciences Inc         | CUSIP: 45166A102<br>LEI: 549300ULW08F62IJML11 | Long             | EC               | CORP              | US        |      8280 | NS      | $266533.20    | 0.73%             |  |  |  | No            |                  1 | On Loan: No      |
| Cogent Biosciences Inc         | Cogent Biosciences Inc         | CUSIP: 19240Q201<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      6690 | NS      | $240237.90    | 0.65%             |  |  |  | No            |                  1 | On Loan: No      |
| GH Research PLC                | GH Research PLC                | CUSIP: 000000000<br>LEI: 875500HKJS7QQG6EWH62 | Long             | EC               | CORP              | IE        |     21612 | NS      | $338443.92    | 0.92%             |  |  |  | No            |                  1 | On Loan: —       |
| Olema Pharmaceuticals Inc      | Olema Pharmaceuticals Inc      | CUSIP: 68062P106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      8524 | NS      | $219237.28    | 0.60%             |  |  |  | No            |                  1 | On Loan: No      |
| Centessa Pharmaceuticals PLC   | Centessa Pharmaceuticals PLC   | CUSIP: 152309100<br>LEI: 213800GIDAARDSKOI827 | Long             | EC               | CORP              | US        |     10626 | NS      | $261080.82    | 0.71%             |  |  |  | No            |                  1 | On Loan: No      |
| Terns Pharmaceuticals Inc      | Terns Pharmaceuticals Inc      | CUSIP: 880881107<br>LEI: 254900S1ZDQMF4MYP709 | Long             | EC               | CORP              | US        |      6261 | NS      | $216630.60    | 0.59%             |  |  |  | No            |                  1 | On Loan: No      |
| Rezolute Inc                   | Rezolute Inc                   | CUSIP: 76200L309<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    156515 | NS      | $522760.10    | 1.42%             |  |  |  | No            |                  1 | On Loan: No      |
| Septerna Inc                   | Septerna Inc                   | CUSIP: 81734D104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     11074 | NS      | $258467.16    | 0.70%             |  |  |  | No            |                  1 | On Loan: No      |
| Relay Therapeutics Inc         | Relay Therapeutics Inc         | CUSIP: 75943R102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     35085 | NS      | $268751.10    | 0.73%             |  |  |  | No            |                  1 | On Loan: No      |
| Ventyx Biosciences Inc         | Ventyx Biosciences Inc         | CUSIP: 92332V107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     34399 | NS      | $479866.05    | 1.31%             |  |  |  | No            |                  1 | On Loan: No      |
| CytomX Therapeutics Inc        | CytomX Therapeutics Inc        | CUSIP: 23284F105<br>LEI: 5493004VW2FW0QLL3345 | Long             | EC               | CORP              | US        |     67237 | NS      | $382578.53    | 1.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Amylyx Pharmaceuticals Inc     | Amylyx Pharmaceuticals Inc     | CUSIP: 03237H101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     21505 | NS      | $307306.45    | 0.84%             |  |  |  | No            |                  1 | On Loan: No      |
| Nektar Therapeutics            | Nektar Therapeutics            | CUSIP: 640268306<br>LEI: 5299005I24806IOIYE03 | Long             | EC               | CORP              | US        |      5150 | NS      | $192249.50    | 0.52%             |  |  |  | No            |                  1 | On Loan: No      |
| Xenon Pharmaceuticals Inc      | Xenon Pharmaceuticals Inc      | CUSIP: 98420N105<br>LEI: 549300XV44Q9Z1MIPQ03 | Long             | EC               | CORP              | CA        |      6393 | NS      | $262176.93    | 0.71%             |  |  |  | No            |                  1 | On Loan: No      |
| Neurogene Inc                  | Neurogene Inc                  | CUSIP: 64135M105<br>LEI: 529900A7VIY892SZVW73 | Long             | EC               | CORP              | US        |     13466 | NS      | $237809.56    | 0.65%             |  |  |  | No            |                  1 | On Loan: —       |
| Viridian Therapeutics Inc      | Viridian Therapeutics Inc      | CUSIP: 92790C104<br>LEI: 549300C775BNYF550E70 | Long             | EC               | CORP              | US        |      8719 | NS      | $287727.00    | 0.78%             |  |  |  | No            |                  1 | On Loan: No      |
| Palvella Therapeutics Inc      | Palvella Therapeutics Inc      | CUSIP: 697947109<br>LEI: 254900AJDH8PAOOI5T33 | Long             | EC               | CORP              | US        |      2857 | NS      | $219103.33    | 0.60%             |  |  |  | No            |                  1 | On Loan: No      |
| Zymeworks Inc                  | Zymeworks Inc                  | CUSIP: 98985Y108<br>LEI: 894500AHOYAGYLYZJL67 | Long             | EC               | CORP              | US        |     11057 | NS      | $249114.21    | 0.68%             |  |  |  | No            |                  1 | On Loan: No      |
| Dianthus Therapeutics Inc      | Dianthus Therapeutics Inc      | CUSIP: 252828108<br>LEI: 549300Z3N6ODPCOFC890 | Long             | EC               | CORP              | US        |      6688 | NS      | $357072.32    | 0.97%             |  |  |  | No            |                  1 | On Loan: No      |
| Viking Therapeutics Inc        | Viking Therapeutics Inc        | CUSIP: 92686J106<br>LEI: 529900IVC72YPFA25M37 | Long             | EC               | CORP              | US        |      7597 | NS      | $220616.88    | 0.60%             |  |  |  | No            |                  1 | On Loan: No      |
| Definium Therapeutics Inc      | Definium Therapeutics Inc      | CUSIP: 24477V105<br>LEI: 549300QY8KN1O6RPFJ13 | Long             | EC               | CORP              | US        |     22449 | NS      | $378939.12    | 1.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Nurix Therapeutics Inc         | Nurix Therapeutics Inc         | CUSIP: 67080M103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     14772 | NS      | $244033.44    | 0.66%             |  |  |  | No            |                  1 | On Loan: No      |
| REGENXBIO Inc                  | REGENXBIO Inc                  | CUSIP: 75901B107<br>LEI: 549300EOES47LATSET33 | Long             | EC               | CORP              | US        |     20313 | NS      | $226693.08    | 0.62%             |  |  |  | No            |                  1 | On Loan: No      |
| Capricor Therapeutics Inc      | Capricor Therapeutics Inc      | CUSIP: 14070B309<br>LEI: 5493002ZI5PDLXV4DX14 | Long             | EC               | CORP              | US        |     10827 | NS      | $237003.03    | 0.64%             |  |  |  | No            |                  1 | On Loan: —       |
| Scholar Rock Holding Corp      | Scholar Rock Holding Corp      | CUSIP: 80706P103<br>LEI: 549300Z1FLPGL4OWJ459 | Long             | EC               | CORP              | US        |      6011 | NS      | $266527.74    | 0.73%             |  |  |  | No            |                  1 | On Loan: No      |
| Mineralys Therapeutics Inc     | Mineralys Therapeutics Inc     | CUSIP: 603170101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      7634 | NS      | $235814.26    | 0.64%             |  |  |  | No            |                  1 | On Loan: No      |
| Precigen Inc                   | Precigen Inc                   | CUSIP: 74017N105<br>LEI: 549300XCWNQU35K64G19 | Long             | EC               | CORP              | US        |     76349 | NS      | $342807.01    | 0.93%             |  |  |  | No            |                  1 | On Loan: No      |
| Mereo Biopharma Group PLC      | Mereo Biopharma Group PLC      | CUSIP: 589492107<br>LEI: 213800U8JQHIJOS5AS09 | Long             | EC               | CORP              | GB        |    129828 | NS      | $57124.32     | 0.16%             |  |  |  | No            |                  1 | On Loan: No      |
| Compass Pathways Plc           | Compass Pathways Plc           | CUSIP: 20451W101<br>LEI: 213800N7CUZIC6QSTZ31 | Long             | EC               | CORP              | GB        |     41800 | NS      | $279642.00    | 0.76%             |  |  |  | No            |                  1 | On Loan: No      |
| Celldex Therapeutics Inc       | Celldex Therapeutics Inc       | CUSIP: 15117B202<br>LEI: 529900F018DMYWH38923 | Long             | EC               | CORP              | US        |     10242 | NS      | $251953.20    | 0.69%             |  |  |  | No            |                  1 | On Loan: No      |
| Lexeo Therapeutics Inc         | Lexeo Therapeutics Inc         | CUSIP: 52886X107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     28837 | NS      | $213682.17    | 0.58%             |  |  |  | No            |                  1 | On Loan: No      |
| Spyre Therapeutics Inc         | Spyre Therapeutics Inc         | CUSIP: 00773J202<br>LEI: 52990017AIJPRH3HQH40 | Long             | EC               | CORP              | US        |      8380 | NS      | $267992.40    | 0.73%             |  |  |  | No            |                  1 | On Loan: No      |
| Taysha Gene Therapies Inc      | Taysha Gene Therapies Inc      | CUSIP: 877619106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     48657 | NS      | $219443.07    | 0.60%             |  |  |  | No            |                  1 | On Loan: No      |
| Vir Biotechnology Inc          | Vir Biotechnology Inc          | CUSIP: 92764N102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     42110 | NS      | $313298.40    | 0.85%             |  |  |  | No            |                  1 | On Loan: No      |
| AnaptysBio Inc                 | AnaptysBio Inc                 | CUSIP: 032724106<br>LEI: 529900HH4WQT03IG1A12 | Long             | EC               | CORP              | US        |      6268 | NS      | $297165.88    | 0.81%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2026-03-31

**Name of Applicant:** ETFis Series Trust I

**Signature:** Brinton W. Frith

**Name of Signer:** Brinton W. Frith

**Title:** Treasurer and Principal Financial Officer